FP7HORIZONH2020
Medical Research Infrastructure Development and Health Services Fund By the Sheba Medical Center
- Country
- ILIsrael
- Defence projects
- 0
- Projects, all programmes
- 32
- As coordinator
- 10
- EU contribution (CORDIS)
- EUR 12,337,323
- Active
- 2008 to 2025
Projects
32 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| RE-ACTRNA Epithelial Approach for Crohn’s Treatment | HORIZON | 2025 | Coordinator | EUR 150,000 |
| KidneyGenRxDeveloping RNA-editing based therapy for renal cystic ciliopathies | HORIZON | 2025 | Coordinator | EUR 150,000 |
| ARTEMISAcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients | HORIZON | 2024 | Participant | EUR 66,000 |
| COMBINE-CTCombining CT diagnostic data and interventional approaches for futureproof cardiology care | HORIZON | 2023 | Participant | EUR 460,000 |
| ThermoBreastAn innovative non-contact and harmless screening modality set to change the course of breast cancer detection and patient monitoring | HORIZON | 2023 | Participant | EUR 197,500 |
| PragmaTILPragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors | HORIZON | 2023 | Participant | EUR 912,969 |
| DEFINITIVEDiagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer | HORIZON | 2023 | Participant | EUR 261,728 |
| BootstrapBoosting Societal Adaptation and Mental Health in a Rapidly Digitalizing, Post-Pandemic Europe | HORIZON | 2023 | Participant | EUR 93,250 |
| GeneCKDDeciphering the genetic basis of chronic kidney disease towards prevention and personalized therapy | HORIZON | 2022 | Coordinator | EUR 1,800,000 |
| CINDERELLAClinical Validation of an AI-based approach to improve the shared decision-making process and outcomes in Breast Cancer Patients proposed for Locoregional treatment | HORIZON | 2022 | Participant | EUR 571,292 |
| VirAReducing networking gaps between Rīga Stradiņš University (RSU) and internationally - leading counterparts in viral infection-induced autoimmunity research | H2020 | 2020 | Participant | EUR 173,038 |
| EJP RDEuropean Joint Programme on Rare Diseases | H2020 | 2019 | Third party | Not stated |
| cureCDFunction of long non-coding RNA in Crohn Disease Ulcer Pathogenesis | H2020 | 2018 | Coordinator | EUR 1,500,000 |
| RECOMBStem-cell based gene therapy for recombination deficient SCID (RECOMB) | H2020 | 2018 | Participant | EUR 57,500 |
| m1ARNATranscriptomic m1A - a new key player in the epitranscriptome arena | H2020 | 2017 | Coordinator | EUR 2,457,500 |
| IEDATIntra Erythrocyte Dexamethasone in the treatment of Ataxia Telangiectasia | H2020 | 2016 | Participant | EUR 270,000 |
| MAMEMMultimedia Authoring and Management using your Eyes and Mind | H2020 | 2015 | Participant | EUR 344,613 |
| PACEPerception and Action in Complex Environments | H2020 | 2015 | Participant | EUR 260,301 |
| BIOCYCLEBIOlogical therapy CYCLEs towards tailored, needs-driven, safer and cost-effective management of Crohn’s disease | H2020 | 2015 | Participant | EUR 165,963 |
| PSYSCANTranslating neuroimaging findings from research into clinical practice | FP7 | 2014 | Participant | EUR 71,100 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.